Carisma Therapeutics Inc at JMP Securities Life Sciences Conference Transcript
Awesome. We're going to go ahead and get started. Good afternoon, everyone. Welcome to the JMP Healthcare Conference here. Next presenting company is Carisma Therapeutics. Carisma is a cell therapy company, quite unique, genetically engineering macrophages. And so here to tell us about the company is CEO, Steven Kelly.
Hello, everyone. Thanks for having us. Wren, appreciate it. JMP, thank you.
As Wren said, we are a unique organization. We're a cell therapy company. We have a fundamental platform looking at using macrophages as a therapeutic. We have a robust platform. We have an exciting pipeline and we have a cadence of readouts over the next 18 months or so.
And so what I'll do is I'll spend the next few minutes going through some forward-looking statements about the company and just try to give you a flavor of what we're working on.
So as I said, we're focused on macrophages. We have a fundamental platform that is uniquely
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
